ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:AND - CA0342231077 - Common Stock
54.97 CAD
+0.01 (+0.02%)
Taking everything into account, AND scores 6 out of 10 in our fundamental rating. AND was compared to 15 industry peers in the Health Care Providers & Services industry. AND scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, AND is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- AND had positive earnings in the past year.
- AND had a positive operating cash flow in the past year.
- In the past 5 years AND has always been profitable.
- In the past 5 years AND always reported a positive cash flow from operatings.
1.2 Ratios
- AND has a better Return On Assets (9.81%) than 80.00% of its industry peers.
- With an excellent Return On Equity value of 15.35%, AND belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
- The Return On Invested Capital of AND (11.76%) is better than 86.67% of its industry peers.
- AND had an Average Return On Invested Capital over the past 3 years of 11.97%. This is above the industry average of 6.98%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROIC | 11.76% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
1.3 Margins
- AND has a better Profit Margin (10.37%) than 86.67% of its industry peers.
- AND's Profit Margin has been stable in the last couple of years.
- AND's Operating Margin of 13.99% is amongst the best of the industry. AND outperforms 86.67% of its industry peers.
- In the last couple of years the Operating Margin of AND has remained more or less at the same level.
- AND has a Gross Margin of 33.85%. This is in the lower half of the industry: AND underperforms 60.00% of its industry peers.
- AND's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% |
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AND is creating some value.
- The number of shares outstanding for AND has been reduced compared to 1 year ago.
- AND has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for AND is higher compared to a year ago.
2.2 Solvency
- AND has an Altman-Z score of 6.13. This indicates that AND is financially healthy and has little risk of bankruptcy at the moment.
- AND's Altman-Z score of 6.13 is amongst the best of the industry. AND outperforms 93.33% of its industry peers.
- AND has a debt to FCF ratio of 1.80. This is a very positive value and a sign of high solvency as it would only need 1.80 years to pay back of all of its debts.
- AND's Debt to FCF ratio of 1.80 is amongst the best of the industry. AND outperforms 100.00% of its industry peers.
- A Debt/Equity ratio of 0.21 indicates that AND is not too dependend on debt financing.
- AND has a Debt to Equity ratio of 0.21. This is amongst the best in the industry. AND outperforms 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Altman-Z | 6.13 |
ROIC/WACC1.44
WACC8.16%
2.3 Liquidity
- AND has a Current Ratio of 1.35. This is a normal value and indicates that AND is financially healthy and should not expect problems in meeting its short term obligations.
- With an excellent Current ratio value of 1.35, AND belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
- A Quick Ratio of 1.30 indicates that AND should not have too much problems paying its short term obligations.
- AND's Quick ratio of 1.30 is amongst the best of the industry. AND outperforms 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
- AND shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.96%.
- The Earnings Per Share has been growing by 14.82% on average over the past years. This is quite good.
- Looking at the last year, AND shows a small growth in Revenue. The Revenue has grown by 0.34% in the last year.
- Measured over the past years, AND shows a quite strong growth in Revenue. The Revenue has been growing by 17.53% on average per year.
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
3.2 Future
- AND is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.62% yearly.
- Based on estimates for the next years, AND will show a small growth in Revenue. The Revenue will grow by 1.95% on average per year.
EPS Next Y6.54%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
EPS Next 5YN/A
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- AND is valuated quite expensively with a Price/Earnings ratio of 35.24.
- Based on the Price/Earnings ratio, AND is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 27.54. AND is valued slightly more expensive when compared to this.
- Based on the Price/Forward Earnings ratio of 28.68, the valuation of AND can be described as expensive.
- Based on the Price/Forward Earnings ratio, AND is valued a bit cheaper than the industry average as 73.33% of the companies are valued more expensively.
- AND is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.31, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.24 | ||
| Fwd PE | 28.68 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AND indicates a somewhat cheap valuation: AND is cheaper than 66.67% of the companies listed in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as AND.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.69 | ||
| EV/EBITDA | 14.03 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AND does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of AND may justify a higher PE ratio.
PEG (NY)5.39
PEG (5Y)2.38
EPS Next 2Y10.13%
EPS Next 3Y8.62%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.87%, AND is not a good candidate for dividend investing.
- AND's Dividend Yield is a higher than the industry average which is at 1.30.
- With a Dividend Yield of 0.87, AND pays less dividend than the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
5.2 History
- The dividend of AND decreases each year by -34.89%.
- AND has been paying a dividend for over 5 years, so it has already some track record.
- AND has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-34.89%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
- AND pays out 26.73% of its income as dividend. This is a sustainable payout ratio.
DP26.73%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
TSX:AND (11/4/2025, 7:00:00 PM)
54.97
+0.01 (+0.02%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-11 2025-11-11/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners76.5%
Inst Owner ChangeN/A
Ins Owners2.53%
Ins Owner ChangeN/A
Market Cap2.15B
Revenue(TTM)650.58M
Net Income(TTM)67.49M
Analysts50
Price Target56.92 (3.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
Yearly Dividend0.42
Dividend Growth(5Y)-34.89%
DP26.73%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.25%
Min EPS beat(2)-19.85%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.2%
Min EPS beat(4)-19.85%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-8.84%
EPS beat(12)3
Avg EPS beat(12)-6.41%
EPS beat(16)5
Avg EPS beat(16)11.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.56%
Min Revenue beat(2)-7.25%
Max Revenue beat(2)-1.87%
Revenue beat(4)0
Avg Revenue beat(4)-3.59%
Min Revenue beat(4)-7.25%
Max Revenue beat(4)-1.87%
Revenue beat(8)1
Avg Revenue beat(8)-3.17%
Revenue beat(12)4
Avg Revenue beat(12)-1.94%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.43%
EPS NY rev (1m)-0.79%
EPS NY rev (3m)-6.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.24 | ||
| Fwd PE | 28.68 | ||
| P/S | 3.31 | ||
| P/FCF | 21.69 | ||
| P/OCF | 17.59 | ||
| P/B | 4.89 | ||
| P/tB | 17.04 | ||
| EV/EBITDA | 14.03 |
EPS(TTM)1.56
EY2.84%
EPS(NY)1.92
Fwd EY3.49%
FCF(TTM)2.53
FCFY4.61%
OCF(TTM)3.13
OCFY5.69%
SpS16.62
BVpS11.23
TBVpS3.23
PEG (NY)5.39
PEG (5Y)2.38
Graham Number19.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.81% | ||
| ROE | 15.35% | ||
| ROCE | 16.09% | ||
| ROIC | 11.76% | ||
| ROICexc | 13.13% | ||
| ROICexgc | 34.45% | ||
| OM | 13.99% | ||
| PM (TTM) | 10.37% | ||
| GM | 33.85% | ||
| FCFM | 15.25% |
ROA(3y)9.88%
ROA(5y)11.71%
ROE(3y)15.44%
ROE(5y)22.37%
ROIC(3y)11.97%
ROIC(5y)12.76%
ROICexc(3y)12.48%
ROICexc(5y)13.78%
ROICexgc(3y)30.54%
ROICexgc(5y)29.2%
ROCE(3y)16.39%
ROCE(5y)17.47%
ROICexgc growth 3Y-1.36%
ROICexgc growth 5Y-1.14%
ROICexc growth 3Y4.48%
ROICexc growth 5Y-13.43%
OM growth 3Y-4.81%
OM growth 5Y-1.42%
PM growth 3Y-21.44%
PM growth 5Y-0.72%
GM growth 3Y-14.76%
GM growth 5Y-10.42%
F-Score5
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 1.8 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 32.65% | ||
| Cap/Sales | 3.56% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.6% | ||
| Profit Quality | 147.02% | ||
| Current Ratio | 1.35 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 6.13 |
F-Score5
WACC8.16%
ROIC/WACC1.44
Cap/Depr(3y)36.55%
Cap/Depr(5y)30.34%
Cap/Sales(3y)3.8%
Cap/Sales(5y)3.06%
Profit Quality(3y)141.22%
Profit Quality(5y)125.45%
High Growth Momentum
Growth
EPS 1Y (TTM)1.96%
EPS 3Y-10.45%
EPS 5Y14.82%
EPS Q2Q%-10.53%
EPS Next Y6.54%
EPS Next 2Y10.13%
EPS Next 3Y8.62%
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y13.91%
Revenue growth 5Y17.53%
Sales Q2Q%-3%
Revenue Next Year0.03%
Revenue Next 2Y1.88%
Revenue Next 3Y1.95%
Revenue Next 5YN/A
EBIT growth 1Y-1.92%
EBIT growth 3Y8.43%
EBIT growth 5Y15.86%
EBIT Next Year74.49%
EBIT Next 3Y25.3%
EBIT Next 5YN/A
FCF growth 1Y6.06%
FCF growth 3Y11.81%
FCF growth 5Y13.66%
OCF growth 1Y-1.91%
OCF growth 3Y13.94%
OCF growth 5Y15.32%
ANDLAUER HEALTHCARE GROUP IN / AND.CA FAQ
What is the ChartMill fundamental rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to AND.CA.
What is the valuation status of ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ChartMill assigns a valuation rating of 3 / 10 to ANDLAUER HEALTHCARE GROUP IN (AND.CA). This can be considered as Overvalued.
How profitable is ANDLAUER HEALTHCARE GROUP IN (AND.CA) stock?
ANDLAUER HEALTHCARE GROUP IN (AND.CA) has a profitability rating of 7 / 10.
What is the earnings growth outlook for ANDLAUER HEALTHCARE GROUP IN?
The Earnings per Share (EPS) of ANDLAUER HEALTHCARE GROUP IN (AND.CA) is expected to grow by 6.54% in the next year.
Is the dividend of ANDLAUER HEALTHCARE GROUP IN sustainable?
The dividend rating of ANDLAUER HEALTHCARE GROUP IN (AND.CA) is 3 / 10 and the dividend payout ratio is 26.73%.